Comments
Drug firm GlaxoSmithKline Pharmaceuticals (GSK) today reported 33.73 per cent decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.
The company had posted a standalone net profit of Rs 152.34 crore in the same period previous fiscal, GSK Pharma said in a filing with the BSE.
The company follows January to December financial year.
The company’s total income declined by 7.02 per cent to Rs 666.02 crore in the July-September quarter, compared to Rs 716.37 crore during the same period last year.
GlaxoSmithKline Pharmaceuticals shares were trading at Rs 2,461.05 per scrip at BSE in the afternoon trade, down 0.80 per cent from their previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.